aBSTRaCT OBJECTıVE: This study was planned for the purpose of adapting and determining the reliability and validity of the Turkish version of the "Dialysis Symptom Index (DSI)" for Turkish hemodialysis patients.
which targets a specific physical or emotional symptom. Patients enrolled in the study were asked to describe the presence (yes/ no) of each symptom at any time during the previous 7 days. The severity of each reported symptom was assessed by asking patients to rate the degree to which the symptom was bothersome by using a 5-point Likert scale (1= "not at all bothersome" to 5= "very much bothersome"). Two scores were generated from the DSI. First, an overall symptom burden score was formulated by totaling the number of symptoms reported as present. Second, a total symptom severity score was generated by summing the severity scores for each reported symptom, with a score of 0 for symptoms that were not reported as present. Using this scoring system, the minimum possible total severity score was 0 if none of the 30 symptoms was present and the maximum potential score was 150 if all of the 30 symptoms were reported and rated as "very much bothersome" (severity score of 5) (6).
Translation procedures
The study was initiated after the permission was obtained from Steven D. Weisbord to adapt the DSI to Turkish. After obtaining a written consent from the authors' of the DSI, the English language version of the DSI was first translated into the Turkish language separately by three bilingual medical and nursing professionals. Another expert reviewed the Turkish translations together for inconsistencies with the original English form and minor revisions were suggested in some areas and Turkish version of the DSI was prepared. Afterwards, it was translated back from Turkish to English by two English language experts (bilingual and employed in the Department of English Language Education at Ege University). The back translated and original forms of the DSI were compared and found to be highly similar in meaning.
Ethical considerations
Written permission to use the DSI was obtained before the commencement of the study. Subsequently, permission to undertake the study was obtained from the Nursing School Ethics Committee and written permission was obtained from the hemodialysis units. Patients who met the inclusion criteria were informed by the investigators on the purpose of the study and invited to participate as volunteers. All were given information about opportunities to withdraw from the study at any stage without detriment to their treatment and care.
data analysis
The data were entered and analyzed with SPSS (SPSS, version 11.0 for Windows). Descriptive statistics (frequencies, means, standard deviations [SD] ) were used to describe the demographics characteristics of the respondents.
Content validity
Content validity refers to the extent to which the instrument measures the phenomena for which it is designed. The validity ınTROduCTıOn Hemodialysis patients can suffer from a number of physical and emotional symptoms due to the comorbid illness, treatmentrelated side effects, lifestyle alteration, and the psychosocial impact of living with end-stage renal disease (1, 2, 3, 4) . Loss of energy, exhaustion, anorexia, pain, nausea, pruritus, shortness of breath, muscle cramps, sexual inadequacy and sleep disturbances are often reported by patients (1, 2) . These symptoms affected negatively the quality of life of patients (1, 2, 5) . A comprehensive evaluation of these symptoms of patients with chronic renal disease provides information about the impact of the disease and the treatment. A multidimensional measurement of the symptoms also provides information that can be used to improve patient care, through education and counseling in order to sustain the physical and psychological well-being of patients (6) . Therefore, these symptoms should be measured by using reliable tools before, during and after the treatment process.
The Dialysis Symptom Index (DSI), developed by Weisbord et al. (2004) , is a self-reported index that assesses symptoms and their severity and is widely used in end-stage renal disease patients ( Table I) . As the original scale is in English, validation of the Turkish version was necessary (Table II) .
The reasons for choosing the DSI included the following: (1) There are no reliable tools for assessing hemodialysis symptoms in Turkey, (2) It is a widely used measurement of symptoms in dialysis patients, and (3) The scoring system is practical.
The aim of this study was to adapt culturally and assess the psychometric properties, including internal reliability, stability (test-retest) reliability, and construct validity of the DSI in a Turkish sample.
mETHOdS

Setting
The study was conducted in two dialysis units in Izmir, Turkey.
Sample
A potential sample of 135 hemodialysis patients who visited 2 dialysis units between September to December 2006 met the following inclusion criteria: They were (1) at least 18 years of age, (2) able to speak Turkish (3) receiving hemodialysis treatment, (4) willing to participate in the study. All participants signed a written consent form prior to participation. If the patients were illiterate, the researcher read the questionnaire items to patients and recorded their responses in order to minimize the burden on patients and decrease the likelihood of missing data. Bu anket formunda sizin geçen hafta yaşadığınız başka semptom belirtilmemiş ise lütfen belirtiniz………………………………………………………………………………….
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Content validity
The content validity index (CVI) was used to determine item validity. A CVI was computed using the proportion of experts who were in agreement about item relevance. Ten experts rated each item of the Turkish version of the DSI based on relevance, clarity and simplicity as 1 (not relevant), 2 (somewhat relevant), 3 (relevant), or 4 (very relevant). The average CVI of 0.82 in the final version indicated adequate content validity (> 0.80) (8, 13 ).
Subsequently, the Turkish version of DSI was pretested on 20 dialysis patients in order to check the clarity of the items. Cronbach's alpha for internal consistency reliability was 0.79 in this group. of the construct is demonstrated by a thorough examination of all the concepts included in the instrument's definition, limitations and dimensions (7, 8, 9 ,10,11).
To test content validity, which included item clarity, the translated version was submitted to a panel of 10 experts (4 nursing instructors at a university nursing school, 4 clinical nurses and 2 doctors who were working in the dialysis centers and were informed about the index. They were asked to rate each item of the Turkish version of the DSI based on confirming the conceptual meaning, clarity and medical terminology as 1 (not relevant), 2 (somewhat relevant), 3 (relevant) or 4 (very relevant). Lastly, the Turkish version of the DSI was created by pre-testing it with 20 hemodialysis patients.
ınternal consistency
The reliability of the Turkish version of the DSI was based on internal consistency and test-retest stability. Internal consistency was assessed by the Cronbach's alpha coefficient, which is a measure of the reliability of each construct. Cronbach's alpha coefficient need to be as close to 1.00 as possible, which indicates the reliability through the measurement of consistency. When Cronbach's alpha coefficent is 1.00, it indicates perfect reliability and 0.00 indicates no reliability. A reliability of 0.80 is considered the lowest acceptable coefficient for a welldeveloped measurement tool (7, 8, 9 ,10,11).
Stability was assessed with kappa values by using a repeated measure design with a one-week interval. A kappa value of < 0.20 is considered slight, ≤ 0.40 is fair, ≤ 0.60 is moderate and ≤0.80 is almost perfect (12). Test-retest reliability was assessed by calculating the kappa in a sample of 120 adults. The retest procedure was conducted 1 week after the first test of the Turkish version of the DSI. Although test-retest kappa values as low as κ = 0.20 have been reported as evidence for reliability, 0.60 is a more realistic measure.
RESulTS
General characteristics of the sample
The sample was composed of a total of 135 patients who were interviewed in the dialysis center. Fifteen patients did not complete the questionnaire forms accurately. The patient questionnaire forms for a total of 120 patients (response rate: 88%) were evaluated in this study. The demographic data of the patients are summarized in Table III . The mean age of the patients was 54 years. Of the patients, 55.8% were male, 74.2% were married, 94.2% were unemployed and 66.7% had completed primary school. Fifty percent (n=60) of the participants had an income equal to their expenses. Sixty-two percent (n=74) of the patients had no other chronic disease, except for renal failure. The mean duration of illness and dialysis in the patients were 75.57±61.18 and 48.14 (41.17) months at the time of the study. The mean frequency of dialysis in patients was 2.99±0.91 day/ week. 
Test-retest
The test-retest reliability of the index was carried out with 120 patients after one week in order to assess the index's stability over time. The Kappa statistics determined for each symptom appearing in the index for the test-retest was between 0.10 to
Reliability ınternal consistency reliability
Cronbach's alpha was 0.84 for the total DSI. Cronbach's alpha coefficients for the 30 items of the DSI ranged between 0.82 and 0.84 (Table IV) . (Table V) .
dıSCuSSıOn
Our main purpose was to provide a practical and validated Turkish tool to enhance the assessment of both disease and treatment-related symptoms of hemodialysis patients in clinical settings. We choose the DSI as the target index for translation and validation for the following reasons. Firstly, there is no tool in Turkey for assessing symptoms of hemodialysis patients. Secondly, we think that the DSI is an appropriate index for hemodialysis patients, because it was easy to understand, timeefficient, and easily applicable to everyday life.
The Turkish version of the DSI indicates good content validity, because the CVI was 0.82 (>0.80) (8, 13 ). The pretesting regarding the content of the Turkish version of the DSI indicated that there was no need to modify its translation or content. However, a large sample size will be needed to correct the semantic equivalence.
In the present study, the index's reliability using testretest procedures was good. Two items had very low kappa values (<0.20) (12). These included diarrhea and difficulty concentrating. These results are consistent with those of Weisbord et al. (2004) who reported that diarrhea and difficulty concentrating had very low kappa values. As stated by Weisbord et al. (2004) , "diarrhea is a transient symptom, which is the likely explanation for this finding". We could not explain why the "difficulty concentrating" symptom had very low kappa values. We think that there is a need to evaluate the causes of this symptom in dialysis patients. Also, we recommend that the DSI should be replicated in a large population in Turkey.
To our knowledge, our study is the first study to investigate the validity and reliability of the DSI in hemodialysis patients in Turkey. From our study, the DSI is validated and reliable in hemodialysis patients and the DSI is a index that could be used in determining the effect of disease and treatment-related symptoms on the quality of life of hemodialysis patients in Turkey.
Relevance to clinical practice
Valid measurement instruments are needed to assess symptoms in Turkish hemodialysis patients, both in research and practice. The DSI is simple to administer and dialysis nurses and other health professionals will be able better identify patients at risk of developing treatment and illness-related symptoms affecting their quality of life by using this equipment in routine clinical practices.
